Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells

被引:159
作者
Sanjabi, Shomyseh [1 ]
Mosaheb, Munir M. [1 ]
Flavell, Richard A. [1 ,2 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT 06520 USA
[2] Howard Hughes Med Inst, Chevy Chase, MD USA
关键词
GROWTH-FACTOR-BETA; MONOCLONAL-ANTIBODY; IMMUNE-RESPONSE; RECEPTOR-ALPHA; MEMORY; EXPRESSION; CONTRACTION; DIFFERENTIATION; INTERLEUKIN-2; INFLAMMATION;
D O I
10.1016/j.immuni.2009.04.020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An effective immune response against infectious agents involves massive expansion of CD8(+) T cells. Once the infection is cleared, the majority of these effector cells die through unknown mechanisms. How is expansion controlled to maximize pathogen clearance and minimize immunopathology? We found, after Listeria infection, plasma transforming growth factor beta (TGF-beta) titers increased concomitant with the expansion of effector CD8(+) T cells. Blocking TGF-beta signaling did not affect effector function of CD8(+) T cells. However, TGF-beta controlled effector cell number by lowering Bcl-2 amounts and selectively promoting the apoptosis of short-lived effector cells. TGF-beta-mediated apoptosis of this effector subpopulation occurred during clonal expansion and contraction, whereas interleukin-15 (IL-15) promoted their survival only during contraction. We demonstrate that the number of effector CD8(+) T cells is tightly controlled by multiple extrinsic signals throughout effector differentiation; this plasticity should be exploited during vaccine design and immunotherapy against tumors and autoimmune diseases.
引用
收藏
页码:131 / 144
页数:14
相关论文
共 56 条
  • [41] IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response
    Rubinstein, Mark P.
    Lind, Nicholas A.
    Purton, Jared F.
    Filippou, Pauline
    Best, J. Adam
    McGhee, Patrick A.
    Surh, Charles D.
    Goldrath, Ananda W.
    [J]. BLOOD, 2008, 112 (09) : 3704 - 3712
  • [42] Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates
    Sarkar, Surojit
    Kalia, Vandana
    Haining, W. Nicholas
    Konieczny, Bogumila T.
    Subramaniam, Shruti
    Ahmed, Rafi
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (03) : 625 - 640
  • [43] T-cell quality in memory and protection: implications for vaccine design
    Seder, Robert A.
    Darrah, Patricia A.
    Roederer, Mario
    [J]. NATURE REVIEWS IMMUNOLOGY, 2008, 8 (04) : 247 - 258
  • [44] Transforming growth factor-β promotes 'death by neglect' in post-activated human T cells
    Sillett, HK
    Cruickshank, SM
    Southgate, J
    Trejdosiewicz, LK
    [J]. IMMUNOLOGY, 2001, 102 (03) : 310 - 316
  • [45] TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
    Thomas, DA
    Massagué, J
    [J]. CANCER CELL, 2005, 8 (05) : 369 - 380
  • [46] The dual adverse effects of TGF-β secretion on tumor progression
    Trapani, JA
    [J]. CANCER CELL, 2005, 8 (05) : 349 - 350
  • [47] Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110
  • [48] Cytokine-induced survival of activated T cells in vitro and in vivo
    Vella, AT
    Dow, S
    Potter, TA
    Kappler, J
    Marrack, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (07) : 3810 - 3815
  • [49] The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
    Waldmann, Thomas A.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (08) : 595 - 601
  • [50] Effector and memory CTL differentiation
    Williams, Matthew A.
    Bevan, Michael J.
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 : 171 - 192